利他主义代理人的最优契约:透析药物的医疗保险支付

Optimal Contracting with Altruistic Agents: Medicare Payments for Dialysis Drugs

American Economic Review · 2023
被引 10
人大 A+FT50ABS 4*

中文导读

利用医疗保险数据估计透析治疗决策的结构模型,发现最优契约能消除过量用药、减少支出,每年节省约3亿美元,对医疗支付政策设计有参考价值。

Abstract

We study health-care provider agency and optimal payments, considering an expensive medication for dialysis patients. Using Medicare claims data we estimate a structural model of treatment decisions, in which providers differ in their altruism and marginal costs, and this heterogeneity is unobservable to the government. In a novel application of nonlinear pricing methods, we empirically characterize the optimal contracts in this environment. The optimal contracts eliminate medically excessive dosages and reduce expenditures, resulting in approximately $300 million in annual gains from better contracting. This approach could be applied to a broad class of problems in health-care payment policy.

最优契约利他主义医疗保险支付透析药物